Thalassemia News and Research

Latest Thalassemia News and Research

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

FerroKin BioSciences initiates international Phase 2 study of FBS0701

FerroKin BioSciences initiates international Phase 2 study of FBS0701

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

HemaQuest closes additional $4M to Series B financing

HemaQuest closes additional $4M to Series B financing

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

CorMedix announces dosing of first patient with CRMD-001 in Phase II clinical trial

CorMedix announces dosing of first patient with CRMD-001 in Phase II clinical trial

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

FerroKin BioSciences announces closing of $12M financing

FerroKin BioSciences announces closing of $12M financing

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Creator of California Tay-Sachs Disease Prevention Program among the honorees

HemaQuest Pharmaceuticals closes $12M Series B financing

HemaQuest Pharmaceuticals closes $12M Series B financing

Innovative drug design wins medical research prize

Innovative drug design wins medical research prize

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics' personal Genetic Health Report now available

Genetix Pharmaceuticals announces completion of $35M Series B financing

Genetix Pharmaceuticals announces completion of $35M Series B financing

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein

Concordia University Professor awarded grant to study molecular mechanisms of virulence factor protein